Accelerate Diagnostics Inc (NASDAQ:AXDX)
| 8.02 Delayed Data As of Apr 16 |  -0.03 / -0.37%Today’s Change | 6.82 Today|||52-Week Range 19.11 | +5.80% Year-to-Date |
Latest AXDX News | Press Releases
No recent news for Accelerate Diagnostics Inc.
Today’s Trading
| Previous close | 8.09 |
| Today’s open | 8.19 |
| Day’s range | 7.85 - 8.19 |
| Volume | 194,953 |
| Average volume (3 months) | 499,094 |
| Market cap | $504.7M |
Data as of 4:00pm ET, 04/16/2021
Growth & Valuation
| Earnings growth (last year) | +9.72% |
| Earnings growth (this year) | +7.38% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +20.09% |
| P/E ratio | NM |
| Price/Sales | 38.03 |
| Price/Book | -- |
Competitors
| ---- | ||
| QTNTQuotient Ltd | -0.03 | -0.72% |
| AWHAspira Women's Healt... | -0.28 | -4.39% |
| GALTGalectin Therapeutic... | -0.04 | -1.79% |
Data as of 3:59pm ET, 04/16/2021
Financials
| Next reporting date | May 13, 2021 |
| EPS forecast (this quarter) | -$0.33 |
| Annual revenue (last year) | $11.2M |
| Annual profit (last year) | -$78.2M |
| Net profit margin | -700.47% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Tucson, Arizona |
Forecasts
